DE602004016841D1 - Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen - Google Patents
Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungenInfo
- Publication number
- DE602004016841D1 DE602004016841D1 DE602004016841T DE602004016841T DE602004016841D1 DE 602004016841 D1 DE602004016841 D1 DE 602004016841D1 DE 602004016841 T DE602004016841 T DE 602004016841T DE 602004016841 T DE602004016841 T DE 602004016841T DE 602004016841 D1 DE602004016841 D1 DE 602004016841D1
- Authority
- DE
- Germany
- Prior art keywords
- psychiatric disorder
- treatment
- treating
- carboxylic derivatives
- tetramethylcyclopropane carboxylic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000020016 psychiatric disease Diseases 0.000 title abstract 4
- SFHVXKNMCGSLAR-UHFFFAOYSA-N 2,2,3,3-tetramethylcyclopropanecarboxylic acid Chemical class CC1(C)C(C(O)=O)C1(C)C SFHVXKNMCGSLAR-UHFFFAOYSA-N 0.000 title 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 2
- 101710113802 Inositol-3-phosphate synthase Proteins 0.000 abstract 2
- 101710090028 Inositol-3-phosphate synthase 1 Proteins 0.000 abstract 2
- 102100036881 Inositol-3-phosphate synthase 1 Human genes 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- -1 2,2,3,3 tetramethylcyclopropane carboxylic acid derivative compounds Chemical class 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL15620303A IL156203A0 (en) | 2003-05-29 | 2003-05-29 | Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders |
| PCT/IL2004/000455 WO2004105746A1 (en) | 2003-05-29 | 2004-05-27 | Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004016841D1 true DE602004016841D1 (de) | 2008-11-13 |
Family
ID=32587598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004016841T Expired - Lifetime DE602004016841D1 (de) | 2003-05-29 | 2004-05-27 | Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100048721A2 (enExample) |
| EP (1) | EP1626710B1 (enExample) |
| JP (1) | JP2007500205A (enExample) |
| AT (1) | ATE409469T1 (enExample) |
| CA (1) | CA2527094A1 (enExample) |
| DE (1) | DE602004016841D1 (enExample) |
| IL (2) | IL156203A0 (enExample) |
| WO (1) | WO2004105746A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL157751A0 (en) | 2003-02-28 | 2004-03-28 | Yissum Res Dev Co | New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them |
| US20060004098A1 (en) * | 2003-07-28 | 2006-01-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compounds useful for treating neurological disorders |
| CN100426897C (zh) | 2005-01-12 | 2008-10-15 | 华为技术有限公司 | 分体式基站系统及其组网方法和基带单元 |
| CN102198121B (zh) * | 2011-04-08 | 2012-05-23 | 广东药学院 | 2,2,3,3-四甲基环丙酰硫脲在制备抗肿瘤药物中的应用 |
| JP2014515408A (ja) * | 2011-06-03 | 2014-06-30 | エラン ファーマシューティカルズ，リミティド ライアビリティー カンパニー | 行動及び精神障害の治療のためのシロ−イノシトール |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9303274D0 (sv) * | 1993-10-07 | 1993-10-07 | Astra Ab | Novel phenylethyl and phenylproplamines |
| IL108595A (en) * | 1994-02-08 | 1998-09-24 | Yissum Res Dev Co | History of Carboxylic Acid 2,2,3,3 Tetramethyl Cyclophen (ACMT) (Process for their Preparation and Pharmaceutical Preparations Containing Them) |
| PL365588A1 (en) * | 2000-07-21 | 2005-01-10 | Teva Pharmaceutical Industries, Ltd. | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder |
| US6610326B2 (en) * | 2001-02-16 | 2003-08-26 | Andrx Corporation | Divalproex sodium tablets |
| IL147953A (en) * | 2002-02-01 | 2008-04-13 | Meir Bialer | Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl- |
-
2003
- 2003-05-29 IL IL15620303A patent/IL156203A0/xx unknown
-
2004
- 2004-05-27 EP EP04735084A patent/EP1626710B1/en not_active Expired - Lifetime
- 2004-05-27 WO PCT/IL2004/000455 patent/WO2004105746A1/en not_active Ceased
- 2004-05-27 AT AT04735084T patent/ATE409469T1/de not_active IP Right Cessation
- 2004-05-27 CA CA002527094A patent/CA2527094A1/en not_active Abandoned
- 2004-05-27 JP JP2006531007A patent/JP2007500205A/ja active Pending
- 2004-05-27 DE DE602004016841T patent/DE602004016841D1/de not_active Expired - Lifetime
- 2004-05-27 US US10/558,408 patent/US20100048721A2/en not_active Abandoned
-
2005
- 2005-11-23 IL IL172134A patent/IL172134A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007500205A (ja) | 2007-01-11 |
| WO2004105746A1 (en) | 2004-12-09 |
| IL156203A0 (en) | 2003-12-23 |
| ATE409469T1 (de) | 2008-10-15 |
| US20100048721A2 (en) | 2010-02-25 |
| IL172134A0 (en) | 2006-04-10 |
| EP1626710A1 (en) | 2006-02-22 |
| EP1626710B1 (en) | 2008-10-01 |
| US20070043122A1 (en) | 2007-02-22 |
| IL172134A (en) | 2011-02-28 |
| CA2527094A1 (en) | 2004-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| DE60219595D1 (de) | Verfahren zur behandlung von erkrankungen mit malonyl coa-decarboxylase-inhibitoren | |
| DE602004017174D1 (de) | Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege | |
| DE60225556D1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
| GEP20053631B (en) | ) New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors | |
| AP1498A (en) | Inhibitors of impdh enzyme. | |
| EA200401365A1 (ru) | Способы лечения илеуса | |
| ATE244717T1 (de) | Inhibitoren des impdh-enzyms | |
| DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
| DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
| BR0311136A (pt) | composto ou um sal, enanciÈmero, diaestereÈmero ou éster hidrolisável in vivo ou mistura dos mesmos farmaceuticamente aceitável, composição, e, método para inibir a atividade de fator letal (lf) liberado de bactérias em um mamìfero | |
| BRPI0514419A (pt) | amidas do ácido tienopirrol carboxìlico substituìdas, amidas do ácido pirrolotiazol carboxìlico, e análogos relacionados como inibidores de caseìna cinase iépsilon, bem como composição farmacêutica e processo para a preparação dos mesmos | |
| DE60018704D1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| DE602004016841D1 (de) | Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| DE60323613D1 (de) | Verwendung von tyrosinkinase-hemmern zur behandlung von erkrankungen im zusammenhang mit substanzgebrauch | |
| DE60027127D1 (de) | Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen | |
| ATE315387T1 (de) | Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz | |
| BR0112123A (pt) | Composto | |
| JO2724B1 (en) | 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors | |
| EP1597234A4 (en) | NEW COMPOUNDS | |
| ATE516038T1 (de) | Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen | |
| ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |